Rhabdomyolysis during therapy with daptomycin.

Stella Papadopoulos; Amanda M. Ball; Susanne E. Liewer; Craig A. Martin; P. Shane Winstead; Brian S. Murphy

doi:10.1086/504379

Rhabdomyolysis during therapy with daptomycin.

Stella Papadopoulos
, Amanda M. Ball
, Susanne E. Liewer
, Craig A. Martin
, P. Shane Winstead
, Brian S. Murphy

Producción científica: Article › revisión exhaustiva

67 Citas (Scopus)

Resumen

The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.

Idioma original	English
Páginas (desde-hasta)	e108-110
Publicación	Clinical Infectious Diseases
Volumen	42
N.º	12
DOI	https://doi.org/10.1086/504379
Estado	Published - jun 15 2006

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Good health and well being

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Acceder al documento

10.1086/504379

Otros archivos y enlaces

Citar esto

@article{7f4a9470aa9640608121f1c28bd85f0e,

title = "Rhabdomyolysis during therapy with daptomycin.",

abstract = "The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8\% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.",

author = "Stella Papadopoulos and Ball, \{Amanda M.\} and Liewer, \{Susanne E.\} and Martin, \{Craig A.\} and Winstead, \{P. Shane\} and Murphy, \{Brian S.\}",

year = "2006",

month = jun,

day = "15",

doi = "10.1086/504379",

language = "English",

volume = "42",

pages = "e108--110",

number = "12",

}

TY - JOUR

T1 - Rhabdomyolysis during therapy with daptomycin.

AU - Papadopoulos, Stella

AU - Ball, Amanda M.

AU - Liewer, Susanne E.

AU - Martin, Craig A.

AU - Winstead, P. Shane

AU - Murphy, Brian S.

PY - 2006/6/15

Y1 - 2006/6/15

N2 - The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.

AB - The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.

UR - https://www.scopus.com/pages/publications/33748636443

UR - https://www.scopus.com/pages/publications/33748636443#tab=citedBy

U2 - 10.1086/504379

DO - 10.1086/504379

M3 - Article

C2 - 16705566

AN - SCOPUS:33748636443

SN - 1058-4838

VL - 42

SP - e108-110

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 12

ER -

Rhabdomyolysis during therapy with daptomycin.

Resumen

ODS de las Naciones Unidas

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto